Lactobacillus Sporogenes (Bacillus Coagulans) Summary
Probiotic therapy in its rudimentary form originated in the Near and Middle East, where ancient physicians prescribed fermented
milks for the treatment of various diseases, including tuberculosis and gastrointestinal disorders. Clinical interest in fermented
milks and their role in human health was triggered by a Russian physician, E. Metchnikoff, who attributed the longevity of people
in the Balkan countries to the regular consumption of fermented milk. The healthful properties of fermented milk are provided by
the indigenous lactobacilli, which are also normal inhabitants of the human gastrointestinal tract, skin and vaginal mucosa.
Lactobacillus therapy has been shown to be effective in the treatment of a variety of disorders, including gastrointestinal
disorders, vaginal infections, hepatic encephalopathy, hypercholesterolemia and conditions related to deficiency of vitamins B.
Lactobacilli have proved to be useful in delaying the induction of tumors and have found use in the prevention of colon cancer.
Lactobacilli are thus valuable therapeutically and are often used as adjuvants to antibiotic therapy. They also find use as growth
enhancers for domestic animals and poultry.
Lactobacilli through their metabolic processes prevent the growth of putrefactive organisms by competitive inhibition, the
generation of a non-conducive acidic environment and the production of bacteriocins. They improve the digestibility of ingested
food constituents and the bioavailability of nutrients, possess hypocholesterolemic activity and enhance the immune response.
The therapeutically used species of Lactobacillus include L. acidophilus, L. brevis, L. casei, L. bulgaricus and L. bifidus.
However, the evidence for effectiveness of implantation, survival and proliferation of these organisms in the gut are not
impressive.
A superior species, which is effectively implanted in the gut, is semi-resident and can survive the gastric acidity and bile is
Lactobacillus sporogenes (Bacillus coagulans). This organism forms spores which are protected by nature’s own
microencapsulation system and germinate into viable cells in the intestine, which can then proliferate extensively. Clinical trials
with L. sporogenes have proven successful in the treatment of gastrointestinal disorders, non-specific vaginitis, aphthous
stomatitis, hepatic encephalopathy and in growth improvement of farm animals. L. sporogenes (B. coagulans) is therefore the
probiotic of choice in clinical applications.
Probiotic therapy in its rudimentary form originated in the Near and Middle East, where ancient physicians prescribed fermented
milks for the treatment of various diseases, including tuberculosis and gastrointestinal disorders. Clinical interest in fermented
milks and their role in human health was triggered by a Russian physician, E. Metchnikoff, who attributed the longevity of people
in the Balkan countries to the regular consumption of fermented milk. The healthful properties of fermented milk are provided by
the indigenous lactobacilli, which are also normal inhabitants of the human gastrointestinal tract, skin and vaginal mucosa.
Lactobacillus therapy has been shown to be effective in the treatment of a variety of disorders, including gastrointestinal
disorders, vaginal infections, hepatic encephalopathy, hypercholesterolemia and conditions related to deficiency of vitamins B.
Lactobacilli have proved to be useful in delaying the induction of tumors and have found use in the prevention of colon cancer.
Lactobacilli are thus valuable therapeutically and are often used as adjuvants to antibiotic therapy. They also find use as growth
enhancers for domestic animals and poultry.
Lactobacilli through their metabolic processes prevent the growth of putrefactive organisms by competitive inhibition, the
generation of a non-conducive acidic environment and the production of bacteriocins. They improve the digestibility of ingested
food constituents and the bioavailability of nutrients, possess hypocholesterolemic activity and enhance the immune response.
The therapeutically used species of Lactobacillus include L. acidophilus, L. brevis, L. casei, L. bulgaricus and L. bifidus.
However, the evidence for effectiveness of implantation, survival and proliferation of these organisms in the gut are not
impressive.
A superior species, which is effectively implanted in the gut, is semi-resident and can survive the gastric acidity and bile is
Lactobacillus sporogenes (Bacillus coagulans). This organism forms spores which are protected by nature’s own
microencapsulation system and germinate into viable cells in the intestine, which can then proliferate extensively. Clinical trials
with L. sporogenes have proven successful in the treatment of gastrointestinal disorders, non-specific vaginitis, aphthous
stomatitis, hepatic encephalopathy and in growth improvement of farm animals. L. sporogenes (B. coagulans) is therefore the
probiotic of choice in clinical applications.
| Cycles of Life 2007 All Rights Reserved Terms of Service Privacy Policy |
| All Natural Probiotic Formulations To Help Establish, Support and Maintain Optimal Intestinal Health |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| Have Questions? Call Us Toll Free 9AM-5PM PST 1-800-498-6640 Order Online 24 Hours A Day 7 Days A Week |
